Revenue for 2Q18 surged to $1.5 million compared to $3,000 a year ago due to the group’s recent acquisitions in the Philippines, Singapore and Indonesia. Topline growth was also boosted by revenue from existing clinics which commenced operations in Singapore and Hong Kong in July 2017, as well as the provision of laboratory testing services.
SINGAPORE (Aug 15): Clearbridge Health announced a loss of $12.2 million for the 2Q ended June, widening from the $0.2 loss it posted a year ago mainly due to fair value losses recorded during the quarter under review.
This brings the group’s losses to a total of $14 million for 1H18 compared to the $25,000 loss recorded in 1H17.
